BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

EBR:BELYS • BE0974314461

0.76 EUR
+0.01 (+1.33%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BELYS. BELYS was compared to 35 industry peers in the Household Durables industry. Both the profitability and financial health of BELYS have multiple concerns. BELYS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • BELYS had a positive operating cash flow in the past year.
  • In the past 5 years BELYS reported 4 times negative net income.
  • Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • With a Return On Assets value of -0.02%, BELYS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • BELYS's Return On Equity of -0.07% is on the low side compared to the rest of the industry. BELYS is outperformed by 60.00% of its industry peers.
  • BELYS has a better Return On Invested Capital (6.48%) than 68.57% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BELYS is below the industry average of 9.53%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • BELYS's Operating Margin of 6.94% is fine compared to the rest of the industry. BELYS outperforms 65.71% of its industry peers.
  • BELYS's Operating Margin has declined in the last couple of years.
  • BELYS has a better Gross Margin (61.34%) than 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of BELYS has remained more or less at the same level.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BELYS is destroying value.
  • The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for BELYS has been reduced compared to a year ago.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.26, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.26, BELYS is doing worse than 85.71% of the companies in the same industry.
  • The Debt to FCF ratio of BELYS is 4.98, which is a neutral value as it means it would take BELYS, 4.98 years of fcf income to pay off all of its debts.
  • BELYS has a better Debt to FCF ratio (4.98) than 71.43% of its industry peers.
  • BELYS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • BELYS has a Debt to Equity ratio of 1.80. This is amonst the worse of the industry: BELYS underperforms 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Altman-Z 0.26
ROIC/WACC0.6
WACC10.85%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.63 indicates that BELYS should not have too much problems paying its short term obligations.
  • BELYS has a Current ratio of 1.63. This is comparable to the rest of the industry: BELYS outperforms 57.14% of its industry peers.
  • BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BELYS has a Quick ratio of 0.90. This is comparable to the rest of the industry: BELYS outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

  • BELYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.85%.
  • The Revenue has decreased by -6.81% in the past year.
  • The Revenue has been growing slightly by 0.43% on average over the past years.
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

  • Based on estimates for the next years, BELYS will show a decrease in Earnings Per Share. The EPS will decrease by -1.41% on average per year.
  • Based on estimates for the next years, BELYS will show a small growth in Revenue. The Revenue will grow by 0.36% on average per year.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Forward Earnings ratio of 4.10 indicates a rather cheap valuation of BELYS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 97.14% of the companies listed in the same industry.
  • BELYS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE N/A
Fwd PE 4.1
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BELYS is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BELYS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.87
EV/EBITDA 3.82
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. Dividend

5.1 Amount

  • No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield 0%

BELYSSE GROUP NV

EBR:BELYS (2/12/2026, 7:00:00 PM)

0.76

+0.01 (+1.33%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-20
Earnings (Next)03-05
Inst Owners12.65%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap27.31M
Revenue(TTM)270.29M
Net Income(TTM)-59.00K
Analysts84.44
Price Target1.63 (114.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.1
P/S 0.1
P/FCF 0.87
P/OCF 0.66
P/B 0.33
P/tB N/A
EV/EBITDA 3.82
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY24.39%
FCF(TTM)0.88
FCFY115.55%
OCF(TTM)1.15
OCFY150.82%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.91%
ROIC 6.48%
ROICexc 7.66%
ROICexgc 15.72%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Debt/EBITDA 3.8
Cap/Depr 48.2%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 106.31%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.26
F-Score4
WACC10.85%
ROIC/WACC0.6
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.43%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y114.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


What is the financial health of BELYSSE GROUP NV (BELYS.BR) stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.